Related Experiment Video
Updated: Dec 27, 2025

06:07
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
6.1K
Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes-Reply
Feng Wang1, Qi Zhao1, Rui-Hua Xu1
1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
JAMA Oncology
|March 6, 2020
Abstract
No abstract available in PubMed .

